191 related articles for article (PubMed ID: 35918299)
1. A rapid and sensitive ultra-performance liquid chromatography tandem mass spectrometry method for determination of anlotinib in plasma and dried blood spots: Method development, validation, and clinical application.
Zhang J; Wang W; Du J; Li C; Wang S; Han Y; Wang H; Zong H; Cheng Z; Tian X
Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9372. PubMed ID: 35918299
[TBL] [Abstract][Full Text] [Related]
2. A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma.
Venkatesh B; Yuile A; McKay MJ; Narayanan S; Wheeler H; Itchins M; Pavlakis N; Clarke SJ; Molloy MP
Ther Drug Monit; 2024 Jun; 46(3):332-343. PubMed ID: 38263583
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
[TBL] [Abstract][Full Text] [Related]
4. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Quantitation of Anlotinib and Osimertinib by Isotope-Labeled UHPLC-MS/MS in Human Plasma: Application in NSCLC Patients.
Liu Y; Lin Z; Luo W; Pei X; She Z; Sha Z; Guan Y; Ming D; Liang J
J Chromatogr Sci; 2024 Apr; 62(4):339-346. PubMed ID: 37070405
[TBL] [Abstract][Full Text] [Related]
6. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical blood samples of patients with non-small cell lung cancer.
Irie K; Shobu S; Hiratsuji S; Yamasaki Y; Nanjo S; Kokan C; Hata A; Kaji R; Masago K; Fujita S; Okada Y; Katakami N; Fukushima S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():1-5. PubMed ID: 29689441
[TBL] [Abstract][Full Text] [Related]
8. Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography - tandem mass spectrometry: Method development and validation.
Bahmany S; Hassanzai M; Flint RB; van Onzenoort HAW; de Winter BCM; Koch BCP
Clin Chim Acta; 2024 Jan; 553():117689. PubMed ID: 38052384
[TBL] [Abstract][Full Text] [Related]
9. Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry.
Andriguetti NB; Hahn RZ; Lizot LF; Raymundo S; Costa JL; da Cunha KF; Vilela RMM; Kluck HM; Schwartsmann G; Antunes MV; Linden R
Clin Biochem; 2018 Apr; 54():123-130. PubMed ID: 29514052
[TBL] [Abstract][Full Text] [Related]
10. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
[TBL] [Abstract][Full Text] [Related]
11. Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometry.
Carniel E; Dos Santos KA; de Andrade de Lima L; Kohlrausch R; Linden R; Antunes MV
J Pharm Biomed Anal; 2022 Feb; 210():114591. PubMed ID: 35033943
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of fluoxetine and norfluoxetine in dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.
da Silva ACC; Raasch JR; Vargas TG; Peteffi GP; Hahn RZ; Antunes MV; Perassolo MS; Linden R
Clin Biochem; 2018 Feb; 52():85-93. PubMed ID: 28987790
[TBL] [Abstract][Full Text] [Related]
13. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
14. A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot.
Zanchetta M; Posocco B; Gagno S; Poetto AS; Orleni M; Canil G; Guardascione M; Puglisi F; Toffoli G
J Pharm Biomed Anal; 2023 Mar; 226():115255. PubMed ID: 36682207
[TBL] [Abstract][Full Text] [Related]
15. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
Oliveira RV; Henion J; Wickremsinhe ER
Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2415-26. PubMed ID: 25303470
[TBL] [Abstract][Full Text] [Related]
16. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
17. Application of the isoniazid assay in dried blood spots using the ultra-performance liquid chromatography-tandem mass spectrometry.
Lee K; Jun SH; Choi MS; Song SH; Park JS; Lee JH; Park KU; Song J
Clin Biochem; 2017 Oct; 50(15):882-885. PubMed ID: 28427917
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
[TBL] [Abstract][Full Text] [Related]
19. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
[TBL] [Abstract][Full Text] [Related]
20. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
